Variant report
Variant | esv3329322 |
---|---|
Chromosome Location | chr12:20930526-20937024 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532941675 | chr12:20931429-20931430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188704675 | chr12:20931432-20931433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553090986 | chr12:20931460-20931461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371660953 | chr12:20931492-20931493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181127486 | chr12:20931497-20931498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549267901 | chr12:20931503-20931504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11494694 | chr12:20931540-20931541 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs183869996 | chr12:20931541-20931542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528650713 | chr12:20931560-20931561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551448525 | chr12:20931603-20931604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10841639 | chr12:20931626-20931627 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs188386869 | chr12:20931658-20931659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543249144 | chr12:20931689-20931690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34467576 | chr12:20931729-20931730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs397757211 | chr12:20931735-20931736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556044701 | chr12:20931764-20931765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569811380 | chr12:20931771-20931772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549622142 | chr12:20931781-20931782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535732651 | chr12:20931787-20931788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180802266 | chr12:20931827-20931828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373541704 | chr12:20931839-20931840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187634296 | chr12:20931855-20931856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11537388 | chr12:20931915-20931916 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs557852813 | chr12:20931923-20931924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577732594 | chr12:20931924-20931925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543395577 | chr12:20931932-20931933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191954482 | chr12:20931979-20931980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574291749 | chr12:20932012-20932013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141923549 | chr12:20932039-20932040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559722009 | chr12:20932047-20932048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75847994 | chr12:20932079-20932080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181932342 | chr12:20932089-20932090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532976161 | chr12:20932115-20932116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564993248 | chr12:20932132-20932133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369635353 | chr12:20932172-20932173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550602195 | chr12:20932174-20932175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115286966 | chr12:20932175-20932176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs151154733 | chr12:20932213-20932214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185730366 | chr12:20932222-20932223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565751247 | chr12:20932231-20932232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190196375 | chr12:20932287-20932288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557888005 | chr12:20932300-20932301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12311665 | chr12:20932321-20932322 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs182635124 | chr12:20932385-20932386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556726884 | chr12:20932386-20932387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573557586 | chr12:20932393-20932394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1829009 | chr12:20932399-20932400 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs1829008 | chr12:20932442-20932443 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs568414023 | chr12:20932462-20932463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186958250 | chr12:20932465-20932466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 16397240 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21364760 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 23813976 | CNVD |
Schizophrenia | 21346763 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:20931400-20933000 | Enhancers | Liver | Liver |
2 | chr12:20931800-20932200 | Enhancers | Adipose Nuclei | Adipose |
3 | chr12:20931800-20932400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |